Pediatric obesity and metabolic syndrome are rising at alarming rates, yet misconceptions and outdated approaches often leave children without timely, effective treatment. In this episode, Dr. Fatima Cody Stanford reframes obesity as a chronic brain-mediated disease, discusses the latest evidence on early intervention, GLP-1 therapies, and bariatric surgery in youth, and addresses weight bias, disparities in access, and systemic policy levers. Listeners will gain practical insights into translating trial data into real-world care, monitoring safety in adolescents, and defining treatment success beyond BMI.

Read Transcript: https://mcdn.podbean.com/mf/web/895hzebsfhwxvd9q/medcast_episode110.pdf

CME Information: https://stanford.cloud-cme.com/medcastepisode110

Claim CE and MOC: https://stanford.cloud-cme.com/Form.aspx?FormID=3516

In an era defined by rapid innovation, the intersection of human-centered medicine and technology is more crucial than ever. Join our host, Dr. Ruth Adewuya, as she reflects on the transformative discussions from season five, where we explored the profound implications of AI, perinatal mental health, climate change, and precision therapeutics. This season has highlighted the path toward more personalized and equitable healthcare, showcasing groundbreaking science and the need for a compassionate approach in medicine. Tune in for an insightful recap that highlights the pivotal moments and ideas that are shaping the future of healthcare.

Read Transcript: https://mcdn.podbean.com/mf/web/6k3jbsprp7tdtb22/medcast_episode109.pdf

CME Information: https://stanford.cloud-cme.com/medcastepisode109

Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=3439

Gene editing is revolutionizing medicine, and Dr. Matthew Porteus, Professor of Pediatrics at Stanford University School of Medicine, is at the forefront of this transformation. Join us for a conversation with Dr. Porteus as he shares his insights on CRISPR technology and its potential to personalize therapies for rare genetic conditions, including sickle cell disease. Discover how this groundbreaking tool not only identifies the root causes of diseases but also paves the way for innovative treatments. As we discuss the challenges of translating gene editing into clinical practice, Dr. Porteus will highlight the ethical considerations and access issues that shape the future of healthcare. Don’t miss this opportunity to explore the promise of CRISPR and its impact on the lives of patients.

Read Transcript

CME Information: https://stanford.cloud-cme.com/medcastepisode108

Claim CE and MOC: https://stanford.cloud-cme.com/Form.aspx?FormID=3420